Charles River Laboratories International - M&A Summary and Business Overview

Life ScienceCompany

Charles River Laboratories International M&A Summary

Charles River Laboratories International has acquired 34 companies, including 11 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 2 assets.

Charles River Laboratories International’s largest acquisition to date was in 2004, when it acquired Inveresk Research Group for $1.5B. Charles River Laboratories International has acquired in 11 different US states, and 7 countries. The Company’s most targeted sectors include life science (91%) and medical products (4%).

Charles River Laboratories International Business Overview

Where is Charles River Laboratories International headquartered?

Charles River Laboratories International is headquartered in Wilmington, Massachusetts.

What is Charles River Laboratories International’s revenue?

Charles River Laboratories International disclosed revenue of 4,129M USD for 2023 and 3,976M USD for 2022.

How many employees does Charles River Laboratories International have?

Charles River Laboratories International has 20,400 employees.

What sector is Charles River Laboratories International in?

Charles River Laboratories International is a life science company.

When was Charles River Laboratories International founded?

Charles River Laboratories International was founded in 1947.

M&A Summary

  • M&A Total Activity33
    • M&A Buy Activity31
    • M&A Sell Activity2
  • Total Sectors Invested 4
  • Total Countries Invested 7
  • M&A Buy/Sell Connections 9
  • M&A Advisors 8

Charles River Laboratories International

Charles River Laboratories International, Inc.

251 Ballardvale Street,
Wilmington, Massachusetts 01887
United States,
(781) 222-6000
www.criver.com

Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.4/yr) # 24 1 4 1 1 - 31
vol $4.3B $1.2B $50M $5.6B
Sell (0.2/yr) # 1 - - - 1 - 2
  33

Most Recent M&A

Company Date Value Type
SAMDI Tech, Inc. 2023-01-30 50M USD Add-on Acquisition
Chicago, Illinois · www.samditech.com
Avian Vaccine Services LLC 2023-01-05 - Divestiture
Norwich, Connecticut · www.avsbio.com
Explora BioLabs 2022-04-06 - Add-on Acquisition
San Diego, California · www.explorabiolabs.com
Vigene Biosciences, Inc. 2021-05-17 293M USD Add-on Acquisition
Rockville, Maryland · www.vigenebio.com
Retrogenix Ltd. 2021-03-31 54M GBP Add-on Acquisition
Chinley, United Kingdom · www.retrogenix.com
Cognate BioServices, Inc. 2021-02-17 875M USD Add-on Acquisition
Memphis, Tennessee · www.cognatebioservices.com
Distributed Bio, Inc. 2021-01-04 - Add-on Acquisition
South San Francisco, California · www.distributedbio.com
Cellero 2020-08-05 - Add-on Acquisition
Lowell, Massachusetts · www.cellero.com
HemaCare Corp. 2019-12-16 380M USD Add-on Acquisition
Northridge, California · www.hemacare.com
CiToxLAB Group 2019-02-13 505M EUR Add-on Acquisition
Cedex, France · www.citoxlab.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 28 (90%) 5.4B (96%) 2 (100%) -
Food 1 (3%) - - -
Information Technology 1 (3%) - - -
Medical Products 1 (3%) 212M (4%) - -
Total 31 $5.6B 2 -

By Geo

State/Country Buy Value Sell Value
United States 20 4.6B 2 -
  Massachusetts 4 64M - -
  California 4 401M - -
  Ohio 2 585M - -
  North Carolina 2 1.5B - -
  Michigan 2 813M - -
  Washington 1 - - -
  Tennessee 1 875M - -
  New York 1 - - -
  Maryland 1 293M - -
  Illinois 1 50M - -
  Delaware 1 17M - -
  Pennsylvania - - 1 -
  Connecticut - - 1 -
United Kingdom 5 266M - -
Germany 2 38M - -
Belgium 1 145M - -
China 1 - - -
Finland 1 - - -
France 1 505M - -
Domestic 20 (65%) 4.6B (83%) 2 (100%) -
Cross-border 11 (35%) 954M (17%) - -
Total 31 $5.6B 2 -

Top M&A Advisors

Financial Deals
Morgan Stanley
1
Credit Suisse Investment Banking
1
BofA Securities
1
Legal Deals
Davis Polk & Wardwell
5
Weil Gotshal & Manges
1
Axinn, Veltrop & Harkrider
1

Deal Values

buy # Total
> $1B 1 $1.5B
$100M to $1B 8 $3.8B
< $100M 8 $303M
TOTAL $5.6B
Largest Inveresk Research Group, Inc.
$1.5B (2004-07-04)

M&A Connections

Deals
Acquired from
Investor(s)
10%
3 (10%)
Strategic(s)
16%
5 (16%)
Divested to
Investor(s)
50%
1 (50%)
Strategic(s)
50%
1 (50%)

 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.